findmyKOL
Clinical trialNCT01990209CompletedPhase 2Interventional

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

SponsorSCRI Development Innovations, LLCEnrollment71Metastatic Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale School of Medicine

    New Haven, Connecticut, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Hope Cancer Center

    Terre Haute, Indiana, United States

  • Baptist Hospital East

    Louisville, Kentucky, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • Cancer Research Consortium of West Michigan

    Grand Rapids, Michigan, United States

  • Cancer Centers of Sw Oklahoma

    Lawton, Oklahoma, United States

  • Tennessee Oncology Pllc

    Chattanooga, Tennessee, United States

  • Tennessee Oncology Pllc

    Nashville, Tennessee, United States

  • Center for Cancer and Blood Disorders

    Fort Worth, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2014
Primary completion
1 May 2021
Completion
1 May 2021
Last update posted
30 Jun 2022
Registered enrollment
71
Registry id
NCT01990209

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.